Seongnam-si, South Korea

Youngdo Shin

USPTO Granted Patents = 1 

Average Co-Inventor Count = 11.0

ph-index = 1


Company Filing History:


Years Active: 2025

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Youngdo Shin: Innovator in Heterocyclic Compounds

Introduction

Youngdo Shin is a prominent inventor based in Seongnam-si, South Korea. He has made significant contributions to the field of pharmaceuticals through his innovative research and development of novel compounds. His work focuses on creating solutions for various medical conditions, showcasing his commitment to advancing healthcare.

Latest Patents

Youngdo Shin holds a patent for "Fused ring heteroaryl compounds and use thereof." This invention provides novel substituted heterocyclic compounds represented by Formula I, or a pharmaceutically acceptable salt, solvate, polymorph, ester, tautomer, or prodrug thereof. The compounds can be utilized as inhibitors of ALK5 and are beneficial in treating chronic fibrosis, vascular disorders, obesity, diabetes, autoimmune diseases, and cancer. He has 1 patent to his name, reflecting his innovative contributions to the field.

Career Highlights

Youngdo Shin is associated with Bisichem Co., Ltd., where he continues to develop groundbreaking pharmaceutical solutions. His work has positioned him as a key player in the industry, contributing to advancements in medical treatments and therapies.

Collaborations

Youngdo collaborates with talented individuals such as Jinwoo Lee and Byungnam Kang. Their combined expertise fosters a creative environment that enhances the development of innovative solutions in the pharmaceutical sector.

Conclusion

Youngdo Shin's contributions to the field of heterocyclic compounds demonstrate his dedication to improving healthcare through innovation. His work not only addresses critical medical issues but also paves the way for future advancements in pharmaceuticals.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…